Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Filings indexed 525 across all filing types
Latest filing 2021-04-13 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-04-13 English
Interim MD&A - English.pdf
Regulatory Filings
2021-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of interim financial statements and MD&A for the interim period ending January 31, 2021. The document is primarily an officer certification letter and does not contain actual financial data or the interim report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (2972 characters), and it is clearly a certification rather than the report itself.
2021-04-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO regarding the review and fair presentation of interim financial statements and interim MD&A for the period ending January 31, 2021. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The content is primarily an officer certification letter, confirming the accuracy and completeness of the interim filings, but it does not contain the actual financial statements or substantive financial data itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2958 characters), and it is a certification rather than the report or announcement of a report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-04-02 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-04-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Therma Bright has received IRB approval and submitted an application to Health Canada to begin a clinical study for its COVID-19 rapid antigen test. It discusses regulatory submissions, clinical trial preparations, and forward-looking statements about the product's development and potential approvals. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement of regulatory progress and clinical study initiation rather than a financial report or detailed investor presentation. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is a regulatory announcement about clinical trial approval and submission to Health Canada, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2021-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.